Time to Rethink Quality of Life Assessment in Patients with Urothelial Cancer in the Current Therapeutic Era?

Affiliations

¹ Centro de Câncer de Brasilia, Instituto Unity de Ensino e Pesquisa, Brasilia, Brazil.
² Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: guptas5@ccf.org.

Editorial

Cristiane Decat Bergerot et al. Eur Urol. 2023 Apr.

. 2023 Apr;83(4):329-330.

doi: 10.1016/j.eururo.2022.06.007. Epub 2022 Jun 30.

¹ Centro de Câncer de Brasilia, Instituto Unity de Ensino e Pesquisa, Brasilia, Brazil.
² Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: guptas5@ccf.org.

No abstract available

Comment on

Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma.
Grivas P, Kopyltsov E, Su PJ, Parnis FX, Park SH, Yamamoto Y, Fong PC, Tournigand C, Climent Duran MA, Bamias A, Caserta C, Chang J, Cislo P, di Pietro A, Wang J, Powles T. Grivas P, et al. Eur Urol. 2023 Apr;83(4):320-328. doi: 10.1016/j.eururo.2022.04.016. Epub 2022 May 30. Eur Urol. 2023. PMID: 35654659 Clinical Trial.